Viewing Study NCT06336434


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-01-24 @ 7:46 AM
Study NCT ID: NCT06336434
Status: WITHDRAWN
Last Update Posted: 2025-07-31
First Post: 2024-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-1-infection View
None Pregnancy View
None Postpartum View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pregnancy View
None Long-acting View
None cabotegravir View
None rilpivirine View
None pharmocokinetics View
None chestfeeding View
None breastfeeding View